Home › Drug Codes › J Codes › J1813 · LYUMJEV U-100
Updated October 1st, 2026

LYUMJEV U-100 J Code: J1813

Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

Login to unlock all benchmarks
Medicare Payment Limit ?
$3.903
/ HCPCS billing unit
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →
Self-Administered Drug Exclusion 7 Medicare Administrative Contractors list J1813 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: CGS, First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
HCPCS Added Date July 1, 2023
Manufacturer A-S Medication Solutions
Route of Administration Intravenous, Subcutaneous
Generic Status Single-Source; Branded
Dosage Type Multi-Dose
Dosage Form Injection, Solution

About LYUMJEV U-100

Lyumjev U-100 is a medication aligned to the HCPCS J Code: J1813 for billing, pricing, and reimbursement purposes in the United States. It is an Insulin drug administered via the intravenous or subcutaneous routes and manufactured by A-S Medication Solutions.

According to CMS Drug Use Information: Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00002-7728-01 Lyumjev Eli Lilly and Company 20 Lyumjev Intravenous In jection 1000 UNI… Login for More
50090-7433-00 Lyumjev A-S Medication Solutions 20 Lyumjev Intravenous In jection 1000 UNI… Login for More
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

LYUMJEV U-100 Pricing & Reimbursement

J1813 Private Payer Reimbursement
$15.08 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Insulin 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J1811 Novo Nordisk Insulin Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812 Novo Nordisk Insulin Insulin (fiasp), per 5 units
J1813 Generic Code (Multiple Manufacturers) Insulin Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
J1814 Eli Lilly Insulin Insulin (lyumjev), per 5 units

LYUMJEV U-100 CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

CMS does not include Lyumjev U-100 (J1813) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1813. Wastage billing guide →

LYUMJEV U-100 Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

diabetes mellitus
Drug Class
Insulin Analog [EPC]Insulin [Chemical/Ingredient]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Lyumjev U-100 billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for LYUMJEV U-100.
Are there any available Lyumjev U-100 patient assistance programs?
LYUMJEV U-100 patient assistance information can be found through ELI LILLY AND COMPANY. Visit Here →
Where can I find Lyumjev U-100 prescribing information?
LYUMJEV U-100 prescribing information can be found at the link below: Visit Here →
Where can I find Lyumjev U-100 side effect information?
Information regarding LYUMJEV U-100's side effects can be found at MedlinePlus Visit Here →
Does billing LYUMJEV U-100 require JZ/JW wastage modifiers?
CMS does not include LYUMJEV U-100 (J1813) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1813. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.